» Articles » PMID: 24196873

Combinatorial Effects of Multiple Enhancer Variants in Linkage Disequilibrium Dictate Levels of Gene Expression to Confer Susceptibility to Common Traits

Overview
Journal Genome Res
Specialty Genetics
Date 2013 Nov 8
PMID 24196873
Citations 229
Authors
Affiliations
Soon will be listed here.
Abstract

DNA variants (SNPs) that predispose to common traits often localize within noncoding regulatory elements such as enhancers. Moreover, loci identified by genome-wide association studies (GWAS) often contain multiple SNPs in linkage disequilibrium (LD), any of which may be causal. Thus, determining the effect of these multiple variant SNPs on target transcript levels has been a major challenge. Here, we provide evidence that for six common autoimmune disorders (rheumatoid arthritis, Crohn's disease, celiac disease, multiple sclerosis, lupus, and ulcerative colitis), the GWAS association arises from multiple polymorphisms in LD that map to clusters of enhancer elements active in the same cell type. This finding suggests a "multiple enhancer variant" hypothesis for common traits, where several variants in LD impact multiple enhancers and cooperatively affect gene expression. Using a novel method to delineate enhancer-gene interactions, we show that multiple enhancer variants within a given locus typically target the same gene. Using available data from HapMap and B lymphoblasts as a model system, we provide evidence at numerous loci that multiple enhancer variants cooperatively contribute to altered expression of their gene targets. The effects on target transcript levels tend to be modest and can be either gain- or loss-of-function. Additionally, the genes associated with multiple enhancer variants encode proteins that are often functionally related and enriched in common pathways. Overall, the multiple enhancer variant hypothesis offers a new paradigm by which noncoding variants can confer susceptibility to common traits.

Citing Articles

Towards functional maps of non-coding variants in cancer.

Wang Y, Hon G Front Genome Ed. 2024; 6:1481443.

PMID: 39544254 PMC: 11560456. DOI: 10.3389/fgeed.2024.1481443.


Functional characterization of QT interval associated SCN5A enhancer variants identify combined additive effects.

Gunamalai L, Singh P, Berg B, Shi L, Sanchez E, Smith A HGG Adv. 2024; 6(1):100358.

PMID: 39354714 PMC: 11532988. DOI: 10.1016/j.xhgg.2024.100358.


Autoimmunity-Associated SNP rs3024505 Disrupts STAT3 Binding in B Cells, Leading to IL10 Dysregulation.

Uvarova A, Zheremyan E, Ustiugova A, Murashko M, Bogomolova E, Demin D Int J Mol Sci. 2024; 25(18).

PMID: 39337678 PMC: 11432243. DOI: 10.3390/ijms251810196.


HyperCas12a enables highly-multiplexed epigenome editing screens.

Melore S, Hamilton M, Reddy T bioRxiv. 2024; .

PMID: 39026853 PMC: 11257430. DOI: 10.1101/2024.07.08.602263.


An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression.

Zhang J, Wang Q, Qi S, Duan Y, Liu Z, Liu J J Transl Med. 2024; 22(1):547.

PMID: 38849954 PMC: 11157841. DOI: 10.1186/s12967-024-05356-8.


References
1.
Bernstein B, Stamatoyannopoulos J, Costello J, Ren B, Milosavljevic A, Meissner A . The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol. 2010; 28(10):1045-8. PMC: 3607281. DOI: 10.1038/nbt1010-1045. View

2.
Davydov E, Goode D, Sirota M, Cooper G, Sidow A, Batzoglou S . Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010; 6(12):e1001025. PMC: 2996323. DOI: 10.1371/journal.pcbi.1001025. View

3.
Peltonen L, Altshuler D, de Bakker P, Deloukas P, Gabriel S, Gwilliam R . Integrating common and rare genetic variation in diverse human populations. Nature. 2010; 467(7311):52-8. PMC: 3173859. DOI: 10.1038/nature09298. View

4.
Pomerantz M, Ahmadiyeh N, Jia L, Herman P, Verzi M, Doddapaneni H . The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet. 2009; 41(8):882-4. PMC: 2763485. DOI: 10.1038/ng.403. View

5.
Giardine B, Riemer C, Hardison R, Burhans R, Elnitski L, Shah P . Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 2005; 15(10):1451-5. PMC: 1240089. DOI: 10.1101/gr.4086505. View